No Data
Strong Week for Alector (NASDAQ:ALEC) Shareholders Doesn't Alleviate Pain of Three-year Loss
It's nice to see the Alector, Inc. (NASDAQ:ALEC) share price up 23% in a week. But the last three years have seen a terrible decline. Indeed, the share price is down a whopping 84% in the last
Why Did Analysts Give Alector, Inc. (ALEC) a Moderate Buy Rating?
Barclays Maintains Alector(ALEC.US) With Buy Rating, Maintains Target Price $12
Barclays analyst Carter Gould maintains $Alector(ALEC.US)$ with a buy rating, and maintains the target price at $12.According to TipRanks data, the analyst has a success rate of 54.4% and a total aver
H.C. Wainwright Maintains Alector(ALEC.US) With Buy Rating, Maintains Target Price $35
H.C. Wainwright analyst Andrew Fein maintains $Alector(ALEC.US)$ with a buy rating, and maintains the target price at $35.According to TipRanks data, the analyst has a success rate of 46.9% and a tota
Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (NASDAQ:ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a
Express News | HC Wainwright & Co. Reiterates Buy on Alector, Maintains $35 Price Target